These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 989256)

  • 1. Intrathecal pharmacotherapy in coma.
    Ogashiwa M; Takeuchi K
    Acta Neurochir (Wien); 1976; 34(1-4):37-44. PubMed ID: 989256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the intrathecal pharmacotherapy. Part I: CDP-choline.
    Ogashiwa M; Takeuchi K; Hara M; Tanaka Y; Okada J
    Int J Clin Pharmacol Biopharm; 1975 Oct; 12(3):327-35. PubMed ID: 1242132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal administration of CDP-choline into the lower lumbar subarachnoid space in two patients with post-traumatic akinetic mutism.
    Tanji H; Takahashi M; Masu K; Kawaguchi Y; Abe H
    Fukushima J Med Sci; 1976 Mar; 22(1-2):31-47. PubMed ID: 1037478
    [No Abstract]   [Full Text] [Related]  

  • 4. CDP-choline in the treatment of cranio-encephalic traumata.
    Lozano R
    J Neurol Sci; 1991 Jul; 103 Suppl():S43-7. PubMed ID: 1940966
    [No Abstract]   [Full Text] [Related]  

  • 5. [A precursor of phospholipids in the treatment of severe traumatic comas].
    Cohadon F; Richer E; Poletto B
    Neurochirurgie; 1982; 28(4):287-90. PubMed ID: 6759958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of citicoline in high dosages in acute cerebrovascular disease].
    Centrone G; Ragno G; Calicchio G
    Minerva Med; 1986 Mar; 77(11):371-3. PubMed ID: 3703329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diurnal variation of serum cortisol and CDP-choline treatment of patients in the vegetative state].
    Saito Y; Kitane Y; Kawaguchi N; Nojima T; Takahashi
    Horumon To Rinsho; 1975 Oct; 23(10):1021-8. PubMed ID: 1238182
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of CDP-choline on the recovery of patients with head injury.
    Calatayud Maldonado V; Calatayud Pérez JB; Aso Escario J
    J Neurol Sci; 1991 Jul; 103 Suppl():S15-8. PubMed ID: 1940960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of acute cerebral infarction with a choline precursor in a multicenter double-blind placebo-controlled study.
    Tazaki Y; Sakai F; Otomo E; Kutsuzawa T; Kameyama M; Omae T; Fujishima M; Sakuma A
    Stroke; 1988 Feb; 19(2):211-6. PubMed ID: 3278412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cerebral protection by CDP choline during surgical action].
    Neidhardt A; Combe M; Combe J; Schipmann N
    Agressologie; 1986 Jun; 27(7):613-5. PubMed ID: 3777355
    [No Abstract]   [Full Text] [Related]  

  • 11. [Rheographic evaluation of the cerebral angio-hemodynamic effects of cytidine diphosphate choline in arteriosclerotic ictal syndromes].
    De Gregorio G; Armeli G; Restivo S; Francolino A
    Boll Soc Ital Cardiol; 1977; 22(3):341-5. PubMed ID: 617280
    [No Abstract]   [Full Text] [Related]  

  • 12. [CDP choline in cerebral vasculopathy: clinical evaluation and instrumental semeiology].
    Corso EA; Arena M; Ventimiglia A; Bizzarro G; Campo G; Rodolico F
    Clin Ter; 1982 Aug; 102(4):379-86. PubMed ID: 6754218
    [No Abstract]   [Full Text] [Related]  

  • 13. CDP-choline: pharmacological and clinical review.
    Secades JJ; Frontera G
    Methods Find Exp Clin Pharmacol; 1995 Oct; 17 Suppl B():1-54. PubMed ID: 8709678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDP-choline: repeated oral dose tolerance studies in adult healthy volunteers.
    Dinsdale JR; Griffiths GK; Castelló J; Maddock J; Ortiz JA; Aylward M
    Arzneimittelforschung; 1983; 33(7A):1061-5. PubMed ID: 6684468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of oral CDP-choline. Drug surveillance study in 2817 cases.
    Lozano Fernández R
    Arzneimittelforschung; 1983; 33(7A):1073-80. PubMed ID: 6684470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability of methyl-14C CDP-choline by oral route.
    Agut J; Font E; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1045-7. PubMed ID: 6684463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of repeatedly given CDP-choline on cardiovascular and tissue injury in spinal shock conditions: investigation of the acute phase.
    Coskun C; Avci B; Ocak N; Yalcin M; Dirican M; Savci V
    J Pharm Pharmacol; 2010 Apr; 62(4):497-506. PubMed ID: 20604840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxotremorine-induced cholinergic syndrome: modifications by levodopa and/or oral cytidine diphosphocholine.
    Saligaut C; Daoust M; Chadelaud M; Moore N; Chretien P; Boismare F
    Methods Find Exp Clin Pharmacol; 1985 Jan; 7(1):5-8. PubMed ID: 3990445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of the effect of CDP in patients with motor disorders of cerebral origin].
    Asirón Yribarren PJ; Bascuas Asta JL; Marín Górriz F; Marín Redondo J; Noguera Lobera AR; Ramos Cristóbal JA
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1978; 6(1):97-104. PubMed ID: 654990
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological study of CDP-choline. Protection against toxicity in a model of experimental hypoxia.
    Tornos ME; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1022-4. PubMed ID: 6684455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.